BenzingaOctober 2, 2026 at 9:19 AM NY25 Days Ago
Regeneron Highlights Promising Ovarian Cancer, Muscle Preservation Trial Data
Regeneron reports positive trial data for ubamatamab in ovarian cancer and trevogrumab for muscle preservation during weight loss.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
